Myriad Genetics patent would harm society

The following is an excerpt.

Myriad argues that they should be allowed to patent the gene because they were the first ones to remove it from the rest of the human genome. These removed or “isolated” genes give the patent-holder exclusive rights to all clinical testing and research on the genes. As a result, Myriad has forced a monopoly on gene research for BRCA1 and BRCA2.

This patent (and subsequent monopoly) is dangerous as it prohibits research on these genes by other companies and laboratories. And since these genes have been connected to hereditary breast cancer, it is now less likely that a gene-based cure will be found.

View the original article here: Myriad Genetics Patent Would Harm Society

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend